内异丸合内异灌肠液联合治疗子宫内膜异位症的临床观察

Clinical Observation of the Therapy to Endometriosis by NEIYI Pill Matches the NEIYI Clyster Liquid

目的:观察内异丸合内异灌肠液联合治疗子宫内膜异位症的临床疗效。方法:对58例经腹腔镜诊断为子宫内膜异位症的患者,采用随机单盲的研究方法分成3组,A组(内异丸组)共16例;B组(内异丸合内异灌肠液组)共24例;C组(丹那唑组)共18例,3组均连续治疗3个月经周期,于治疗3个月经周期后按中国中西医结合学会妇产科专业委员会第三届学术会议修定的子宫内膜异位症中西医结合诊疗标准进行疗效评定。结果:治疗3个月经周期后,A组痊愈率为56.3%,显效率为37.5%;B组痊愈率为58.3%,显效率为29.2%;C组痊愈率为11.1%,显效率为66.7%。治疗后3组间疗效判定结果经秩和检验:B组疗效优于A组,优于C组。

Objective ： Observing the effect of the therapy to Endometriosis by NEIYI Pill matches the NEIYI Clyster Liquid.Methods ：58 cases who were diagnosized Endometfiosis , were divided into three sets with single blind research in machine method, 16 cases in A set（ cured by NEIYI Pill ）, 24 cases in B set （cured by NEIYI Pill matches the NEIYI Clyster Liquid ） ; 18 cases in C set（ cured by Danasol ）. Three sets were accepted continuing therapy for three menstruation period, they were graded after cu- ring three menstruation period according to Chinese Association of the Intcrgration of Traditional and Western Medicine＇s the third scholarship meeting of Gynecology and Obstetrics Committee fixing the diagnosise and treatment standard of Endometfiosis. Result ： After three menstruation period , in A set the cure rate is 56.3%, effective rate is 37.5% ; in B set the cure rate is 58.3%, effective rate is 29.2% ; in C set the cure rate is 11.1%, effective rate is 66.7%. According to the T test , the conclusion is that the cure effect B set is better than A set, and B set is better than C set.